2011Journal of Shanxi Medical College for Continuing EducationRequires access

Therapeutic Observation of Octreotide in Treatment of Malignant Bowel Obstruction

Peng Dai

Open publisher page 0 citations

Abstract

Objective:To investigate the effect of octreotide in treatment of malignant bowel obstruction.Methods:Forty-eight patients with malignant bowel obstruction without surgical indication were randomly divided into an octreotide group(n=25) and a control group(n=23).The two groups were treated with traditional treatment of fasting,gastrointestinal decompression,supplementing fluid and correcting water electrolysis balance.Based on the traditional treatment,the octreotide group was injected octreotide 0.2 mg hypodermically(once every 6 h or 8 h) for 3 to 14 days continually.Results:The symptom remission rate in the octreotide group was 80%,the average anal exhaust time was 4.7 days and the incidence of side effect was 12 %.The symptom remission rate in the control group was 27%,the average anal exhaust time was 7 days and the incidence of side effect was 43.5%.Conclusion:The effect of octreotide is content in treatment of malignant bowel obstruction and it could reverse bowel obstruction in the early stage of malignant bowel obstruction.

About this research paper

What this paper is about

Objective:To investigate the effect of octreotide in treatment of malignant bowel obstruction.Methods:Forty-eight patients with malignant bowel obstruction without surgical indication were randomly divided into an octreotide group(n=25) and a control group(n=23).The two groups were treated with traditional treatment of fasting,gastrointestinal decompression,supplementing fluid and correcting water electrolysis balance.Based on the traditional treatment,the octreotide group was injected octreotide 0.2 mg hypodermically(once every 6 h or 8 h) for 3 to 14 days continually.Results:The symptom remission rate in the octreotide group was 80%,the average anal exhaust time was 4.7 days and the incidence of side effect was 12 %.The symptom remission rate in the control group was 27%,the average anal exhaust time was 7 days and the incidence of side effect was 43.5%.Conclusion:The effect of octreotide is content in treatment of malignant bowel obstruction and it could reverse bowel obstruction in the early stage of malignant bowel obstruction.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective:To investigate the effect of octreotide in treatment of malignant bowel obstruction.Methods:Forty-eight patients with malignant bowel obstruction without surgical indication were randomly divided into an octreotide group(n=25) and a control group(n=23).The two groups were treated with traditional treatment of fasting,gastrointestinal decompression,supplementing fluid and correcting water electrolysis balance.Based on the traditional treatment,the octreotide group was injected octreotide 0.2 mg hypodermically(once every 6 h or 8 h) for 3 to 14 days continually.Results:The symptom remission rate in the octreotide group was 80%,the average anal exhaust time was 4.7 days and the incidence of side effect was 12 %.The symptom remission rate in the control group was 27%,the average anal exhaust time was 7 days and the incidence of side effect was 43.5%.Conclusion:The effect of octreotide is content in treatment of malignant bowel obstruction and it could reverse bowel obstruction in the early stage of malignant bowel obstruction.

Key concepts: Medicine, Octreotide, Bowel obstruction, Gastroenterology, Incidence (geometry), Surgery, Decompression, Internal medicine

Related papers

Back to paper searchBrowse research topicsOriginal source
Therapeutic Observation of Octreotide in Treatment of Malignant Bowel Obstruction — Research Paper | ScholarLens